Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: A journey from calcitonin back to its precursors

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 4, 2004, Pages 1512-1525

  Becker, K L ^a,c   Nylen E S ^a   White, J C ^a   Muller B ^b   Snider Jr , R H ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; NITRIC OXIDE; PEPTIDE; PROCALCITONIN; MESSENGER RNA; PROTEIN PRECURSOR;

HAMSTER; HUMAN; INFECTION; INFLAMMATION; MONOCYTE; MULTIGENE FAMILY; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SEPSIS; SWINE; ANIMAL; GENETICS; METABOLISM;

CRICETINAE; SUS SCROFA;

ANIMALS; CALCITONIN; HUMANS; INFECTION; MULTIGENE FAMILY; PROTEIN PRECURSORS; RNA, MESSENGER; SEPSIS;

EID: 1942441026     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021444     Document Type: Review

References (186)

1. Copp DH, Davidson AG 1961 Evidence for a new parathyroid hormone which lowers blood calcium. Proc Soc Biol Med 107:342-344
2. Hirsch PF, Gauthier GG, Munson PL 1963 Thyroid hypocalcemic principle and recurrent laryngeal nerve injury as factors affecting the response to parathyroidectomy in rats. Endocrinology 73:244-251
3. Nonidez JF 1932 The origin of the 'parafollicular' cell, a second epithelial component of the thyroid gland in the dog. Am J Anat 49:479
4. Foster GV, MacIntyre I, Pearse AGE 1964 Calcitonin production and the mitochondrion-rich cells of the dog thyroid. Nature 203:1029-1031
5. Meyer JS, Abdel-Bari W 1968 Granules and thyrocalcitonin-like activity in medullary carcinoma of the thyroid gland. N Engl J Med 278:523-529
6. Wolfe HJ, Melvin KEW, Cervi-Skinner SJ, Al Saadi AA, Juliar JF, Jackson CE, Tashjian Jr AH 1973 C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med 289:437-441
7. McMillan PJ, Hooker WM, Deftos LJ 1974 Distribution of calcitonin-containing cells in human thyroid. Am J Anat 140:73-79
8. LeDouarin N, LeLievre C 1970 Demonstration of neural origin of calcitonin cells of ultimobranchial body of chick embryo. C R Acad Sci Hebd Seances Acad Sci D 270:2857-2860
9. Williams ED 1966 Histogenesis of medullary carcinoma of the thyroid. J Clin Pathol 19:114-118
10. Neher R, Riniker B, Rittel W, Zuber H 1968 Menschliches calcitonin III. Struktur von calcitonin M und D. Helv Chim Acta 51:1900-1905
11. Byfield PG, Turner K, Galante L, Gudmundsson TV, MacIntyre I, Riniker B, Nehe, R, Maier R, Kahnt FW 1969 The isolation of human calcitonin. Biochem J 111:13P-14P
12. Potts Jr JT, Niall HD, Keutmann HT, Brewer HB, Deftos LJ 1968 The amino acid sequence of porcine thyrocalcitonin. Proc Natl Acad Sci USA 59:1321-1328
13. Tashjian Jr AH, Howland BG, Melvin KEW, Stratton Hill Jr C 1970 Immunoassay of human calcitonin. N Engl J Med 283:890-895
14. Clark MB, Byfield PGH, Boyd GW, Foster GVA 1969 radioimmunoassay for human calcitonin M. Lancet 2:74-77
15. Deftos LJ, Bury AE, Habener JF, Singer FR, Potts Jr JT 1971 Immunoassay for human calcitonin II. Clinical studies. Metabolism 20:1129-1137
16. Parthemore JG, Bronzert D, Roberts G, Deftos LJA 1974 Short calcium infusion in the diagnosis of medullary thyroid carcinoma. J Clin Endocrinol Metab 39:108-111
17. Hennessey JF, Wells Jr SA, Ontjes DA, Cooper CW 1974 A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of medullary carcinoma of the thyroid. J Clin Endocrinol Metab 39:487-495
18. Hoff AO, Cote GJ, Gagel RF 2000 Multiple endocrine neoplasias. Annu Rev Physiol 62:377-411
19. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Manelli M, Pacini F, Ponder BA, Raue F, Skogseid P, Tamburrano G, Takker RV, Thompson MW, Tamassehi P, Tonelli F, Wells Jr SA, Mara SJ 2001 Guidelines for diagnosis and therapy of MEN type I and type 2. J Clin Endocrinol Metab 86:5658-5671
20. Singer FR, Habener JF 1974 Multiple immunoreactive forms of calcitonin in human plasma. Biochem Biophys Res Commun 61:660-666
21. Roos BA, Okano K, Deftos LJ 1974 Evidence for a pro-calcitonin. Biochem Biophys Res Commun 60:134-140
22. Moukhtar MS, Jullienne A, Taboulet J, Calmettes C, Raulais D, Milhaud G 1975 Heterogeneity of immunoreactive calcitonin in the plasma of patients with bone marrow cancer. Pathol Biol 23:809-814
23. Deftos LJ, Roos BA, Bronzert D, Parthemore JG 1975 Immunochemical heterogeneity of calcitonin in plasma. J Clin Endocrinol Metab 40:409-412
24. Snider RH, Silva OL, Moore CF, Becker KL 1977 Immunochemical heterogeneity of calcitonin in man: effect on radioimmunoassay. Clin Chim Acta 76:1-14
25. Moya F, Nieto A, Candela LL 1975 Calcitonin biosynthesis: evidence for a precursor. Eur J Biochem 55:407-413
26. Goltzman D, Tischler AS 1978 Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture. J Clin Invest 61:449-458
27. Goodman RH, Jacobs JW, Habener JF 1979 Cell-free translation of messenger RNA coding for a precursor of human calcitonin. Biochem Biophys Res Commun 91:932-938
28. LeMoullec JM, Jullienne A, Chenais J, Lasmoles F, Guliana JM, Milhaud G, Moukhtar MS 1984 The complete sequence of human preprocalcitonin. FEBS Lett 167:93-97
29. Treilhou-Lahille F, Pidoux E, Day F, Milhaud G, Moukhtar MS 1986 Granular and extra-granular forms of immunoreactive calcitonin in normal rat "C" cells. Biol Cell 57:221-230
30. Snider RH, Nylén ES, Becker KL 1998 Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Invest Med 552-560
31. Becker KL, Müller B, Nylen ES, Cohen R, White JC, Snider RH 2002 Calcitonin gene family of peptides. Structure molecular biology, and effects. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology, 2nd ed. San Diego: Academic Press; 619-639
32. Deftos LJ 1979 Calcitonin. In: Gray CH, James VHT, eds. Hormones and blood. London: Academic Press, Inc.; 97-141
33. Sexton PM, Findlay DM, Martin TJ 1999 Calcitonin. Curr Med Chem 6:1067-1093
34. Inzerillo AM, Zaidi M, Huang CL-H 2002 Calcitonin: the other hormone. Thyroid 12:791-798
35. Riniker B, Neher R, Maier R, Kahnt FW, Byfield PGH, Gudmundsson TV, Galante L, MacIntyre I 1968 Menschliches calcitonin. I. Isolierung and charakterisierung. Helv Chim Acta 51:1938
36. Riniker B, Brugger M, Kamber B, Rittel W, Sieber P, Neher R 1969 Structure and synthesis of human calcitonin M. Biochem J 111:14P
37. Motté P, Vauzelle P, Gardet P, Ghillani P, Caillou B, Parmentier C, Bohuon C, Bellet D 1988 Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies. Clin Chim Acta 174:35-54
38. Guilloteau D, Perdrisot R, Calemettes C, Baulieu JL, Lecomte P, Kaphan G, Milhaud G, Bernard JC, Jallet P, Bigorgne JC 1990 Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT. J Clin Endocrinol Metab 71:1064-1067
39. Seth R, Moote P, Kehely A, Wimalawansa S, Self CH, Bohuon KC, Bettet D, MacIntyre I 1989 The development of a two-site enzyme immunometric assay (EIA) for calcitonin and its application in the measurement of the hormone in normal subjects, MCT patients and postmenopausal women. Horm Metab Res 21(Suppl):3-5
40. Pondel M 2000 Calcitonin and calcitonin receptors: bone and beyond. Int J Exp Pathol 81:405-422
41. Hirsch PF, Lester GE, Talmage RV 2001 Calcitonin, an enigmatic hormone: does it have a function? J Musculoskelet Neuron Interact 1:299-305
42. Ardaillou R, Vuagnat P, Milhaud G, Richet G 1967 Effects of thyrocalcitonin on the renal excretion of phosphates, calcium and hydrogen ions in man. Nephron 4:298-314
43. Jonderko K, Bueno L 1997 Effect of peripherally and centrally administered calcitonin on gallbladder emptying in dogs. Gastroenterology 32:380-388
44. Becker KL 1993 The coming of age of a bronchial epithelial cell. Am Rev Respir Dis 148:1166-1168
45. Dubay D, Ephgrave KS, Cullen JJ, Broadhurst KA 2003 Intracerebroventricular calcitonin prevents stress-induced gastric dysfunction. J Surg Res 119:188-192
46. Hoff AO, Catala-Lehnen P, Thomas PM, Priemel M, Rueger JM, Nasonkin I, Bradley A, Hughes MR, Ordonez N, Cote GJ, Amling M, Gagel RF 2002 Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. J Clin Invest 110:1849-1857
47. Zaidi M, Alam ASMT, Shankar VS, Bax BE, Moonga BS, Bevis PJR, Pazianas M, Huang CLHA 1992 quantitative description of components of in vitro morphometric change in the rat osteoclast model: relationships with cellular function. Eur Biophys J 21:349-355
48. Zaidi M, Shankar VS, Adebanjo OA, Lai FA, Pazianas M, Sunavala G, Speilman AI, Rifkin BR 1996 Regulation of extracellular calcium sensing in rat osteoclasts by femtomolar calcitonin concentrations. Am J Physiol 271: F637-F644
49. Farley J, Dimai HP, Stilt-Coffing B, Farley F, Pham T, Mohan S 2000 Calcitonin increases the concentration of insulin-like growth factors in serum-free cultures of human osteoblast-like cells. Calcif Tissue Int 67:247-254
50. Friedman J, Raisz LG 1965 Thyrocalcitonin: inhibitor of bone resorption in tissue culture. Science 150:1465-1467
51. Hurley DL, Tiegs RD, Wahner HW, Heath H 1987 Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin. N Engl J Med 317:537-541
52. Marx SJ, Woodard CJ, Aurbach GD 1972 Calcitonin receptors of kidney and bone. Science 178:999-1001
53. Goltzman D, Mitchell J 1985 Interaction of calcitonin and calcitonin gene-related peptide at receptor sites in target tissues. Science 227:1343-1345
54. Nicholson GC, D'Santos CS, Evans T, Moseley JM, Kemp BE, Michelangeli VP, Martin TJ 1988 Human placental calcitonin receptors. Biochem J 250: 877-882
55. Bracq S, Machairas M, Clement B, Pidoux E, Andreoletti M, Moukhtar MS, Jullienne A 1993 Calcitonin gene expression in normal human liver. FEBS Lett 331:15-18
56. Lin HY, Harris TL, Flannery MS, Aruffo A, Kaji EH, Gorn A, Kolakowski LFJ, Lodish HF, Goldring SR 1991 Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 254:1022-1024
57. Gorn AH, Lin HY, Yamin M, Auron PE, Flannery MR, Tapp DR, Lodish HF, Krane SM, Goldring SR 1992 Cloning, characterization and expression of human calcitonin receptor from an ovarian carcinoma cell line. J Clin Invest 90:1726-1735
58. Goldring SR, Gorn AH, Yamin M, Krane SM, Wang JT 1993 Characterization of the structural and functional properties of cloned calcitonin receptor cDNAs. Horm Metab Res 25:477-480
59. Moore EE, Kuestner RE, Stroop SD, Grant FJ, Matthewes SL, Brady CL, Sexton PM, Findlay DM 1995 Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript. Mol Endocrinol 9:959-968
60. Braga V, Sangalli A, Malerba G, Mottes M, Mirandola S, Gatti D, Rossini M, Zamboni M, Adam S 2002 Relationship among VDR (BsmI and FokI), COLIA1, and CTR polymorphisms with bone mass, bone turnover markers, and sex hormones in men. Calcif Tissue Int 70:457-462
61. Chen Y, Shyu JF, Santhanagopal A, Inoue D, David JP, Dixon SJ, Horne WC, Baron R 1998 The calcitonin receptor stimulates Shc tyrosine phosphorylation and Erk1/2 activation. Involvement of Gi, protein kinase C, and calcium. J Biol Chem 273:19809-19816
62. Downs Jr RW, Bell NH, Ettinger MP, Walsh BW, Favus MJ, Mako B, Wang L, Smith ME, Gormley GJ, Melton ME 2000 Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women. J Clin Endocrinol Metab 85:1783-1788
63. Overgaard K, Hansen MA, Jensen SB, Christiansen C 1992 Effects of salmon calcitonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose response study. BMJ 305:556-561
64. Nieves JW, Komar L, Cosman F, Lindsay R 1998 Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis. Am J Clin Nutr 67:18-24
65. Marcus R, Wong M, Heath III H, Stock JL 2002 Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocr Rev 23:16-37
66. Siris ES 1999 Goals of treatment for Paget's disease of bone. J Bone Miner Res 14(Suppl 2):49-52
67. Drake WM, Kendler DL, Brown JP 2001 Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Clin Ther 23:620-626
68. Avioli LV 1998 The role of calcitonin in the prevention of osteoporosis. Endocrinol Metab Clin North Am 27:411-418
69. Body JJ, Mancini L 2003 Treatment of tumor-induced hypercalcemia: a solved problem? Expert Rev Anticancer Ther 3:241-246
70. Mehta NM, Malootian A, Gilligan JP 2003 Calcitonin for osteoporosis and bone pain. Curr Pharm Des 9:2659-2676
71. Roth A, Kolaric K 1986 Analgesic activity of calcitonin in patients with painful osteolytic metastases of breast cancer. Results of a controlled randomized study. Oncology 43:283-287
72. Martinez MJ, Roque M, Alonso-Coello P, Catala E, Garcia JL, Ferrandiz M 2003 Calcitonin for metastatic bone pain. Cochrane Database Syst Rev 3:CD003223
73. Mehta NM, Gilligan JP, Jones BN, Bertelsen AH, Roos BA, Birnbaum RS 1988 Purification of a peptidylglycine α-amidating enzyme from transplantable rat medullary thyroid carcinomas. Arch Biochem Biophys 261:44-54
74. Kurabuchi S, Tanaka S 2002 Immunocytochemical localization of prohormone convertases PCI and PC2 in the mouse thyroid gland and respiratory tract. J Histochem Cytochem 50:903-909
75. Ghillani PP, Motte P, Troalen F, Jullienne A, Gardet P, Le Chevalier T, Rougier P, Schlumberger M, Bohuon C, Bellet D 1989 Identification and measurement of calcitonin precursors in patients with malignant diseases. Cancer Res 49:6845-6851
76. Whang KT, Steinwald PM, White JC, Nylén ES, Snider RH, Simon GL 1998 Serum calcitonin precursors in sepsis and systemic infection. J Clin Endocrinol Metab 83:3296-3301
77. Conlon JM, Grimelius L, Thim L 1988 Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma. Biochem J 256:245-250
78. Roos BA, Huber MB, Birnbaum RS, Aron DC, Lindall AW, Lips K, Baylin SB 1983 Medullary thyroid carcinomas secrete a noncalcitonin peptide corresponding to the carboxyl-terminal region of preprocalcitonin. J Clin Endocrinol Metab 56:802-807
79. Ittner L, Dambacher MA, Born W, Ketelslegers M, Buysschaert M, Albert PM, Lambert AE, Fischer JA 1985 Diagnostic evaluation of measurements of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene in human serum. J Clin Endocrinol Metab 61:1133-1137
80. Born W, Beglinger C, Fischer JA 1991 Diagnostic relevance of the amino-terminal cleavage peptide of procalcitonin (PAS-57), calcitonin and calcitonin gene-related peptide in medullary thyroid carcinoma patients. Regul Pept 32:311-319
81. Bihan H, Becker KL, Snider RH, Nylen E, Vittaz L, Lauret C, Modigliani E, Moretti JL, Cohen R 2003 Calcitonin precursor levels in human medullary thyroid carcinoma. Thyroid 13:819-822
82. Morgenthaler NG, Struck J, Fischer-Schultz C, Bergmann A 2002 Sensitive immunoluminometric assay for the detection of procalcitonin. Clin Chem 48:788-790
83. Becker KL, Snider RH, Silva OL, Moore CF 1978 Calcitonin heterogeneity in lung cancer and medullary thyroid cancer. Acta Endocrinol 89:89-99
84. Becker KL, Silva OL, Snider RH, Moore CF, Geelhoed GW, Mash D, O'Neill WJ, Fink RJ, Murphy TM, Klass EM, Rohatge PK 1984 The pathophysiology of pulmonary calcitonin. In: Becker KL, Gazdar AF, eds. The endocrine lung in health and disease. Philadelphia: WB Saunders Co.; 272-299
85. Silva OL, Broder LE, Doppman JL, Snider RH, Moore CF, Cohen MH, Becker KL 1979 Calcitonin as a marker for bronchogenic cancer: a prospective study. Cancer 44:680-684
86. Becker KL, Monaghan KG, Silva OL 1980 Immunocytochemical localization of calcitonin in Kultschitzky cells of human lung. Arch Path Lab Metab 104:196-198
87. Becker KL, Gazdar AF 1985 What can the biology of small cell cancer teach us about the endocrine lung? Biochem Pharmacol 34:155-159
88. Tabassian AR, Nylen ES, Linnoila RI, Cassidy MM, Becker KL 1989 Stimulation of hamster pulmonary neuroendocrine cells and associated peptides by repeated exposure to cigarette smoke. Am Rev Respir Dis 140:436-440
89. Kelley MJ, Becker KL, Rushin JM, Venson D, Phelps R, Ihde DC, Bliss Jr DP, Melby K, Snider RH, Johnson BE 1994 Calcitonin elevation in small cell lung cancer without ectopic production. Am J Respir Crit Care Med 149: 183-190
90. Becker KL, Nash D, Silva OL, Snider RH, Moore CF 1981 Increased serum and urinary calcitonin in pulmonary disease. Chest 79:211-216
91. Simmons RE, Hjelle JT, Mahoney C, Deftos LJ, Lisker W, Kato P, Rabkin R 1988 Renal metabolism of calcitonin. Am J Physiol 254:F593-F600
92. Silva OL, Becker KL, Shalhoub RJ, Snider RH, Bivins LE, Moore CF 1977 Calcitonin levels in chronic renal disease. Nephron 19:12-18
93. Lee JC, Parthemore JG, Deftos LJ 1977 Immunochemical heterogeneity of calcitonin in renal failure. J Clin Endocrinol Metab 45:528-533
94. Bone RC 1995 Sepsis, sepsis syndrome and the systemic inflammatory response syndrome (SIRS). JAMA 273:155-156
95. Levy M, Fink P, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent J-L, Ramsay G 2003 For the international sepsis definitions conference. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250-1256
96. Ryan CM, Yarmush ML, Burke JF, Tompkins RG 1992 Increased gut permeability early after burns correlates with the extent of burn injury. Crit Care Med 20:1508-1512
97. Ammori BJ, Becker KL, Kite P, Snider RH, Nylén ES, White JC, Barclay GR, Larvin M, McMahon MJ 2003 Calcitonin precursors: early markers of gut barrier dysfunction in patients with acute pancreatitis. Pancreas 27:239-243
98. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR 2001 Epidemiology of severe sepsis in the United States: incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310
99. Chesney RW, McCarron DM, Haddad JG, Hawker CD, DiBella FP, Joan Chesney P, David JP 1983 Pathogenic mechanism of the hypocalcemia of the staphylococcal toxic-shock syndrome. J Lab Clin Med 101:576-585
100. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C 1993 High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515-518
101. Nylén ES, O'Neill W, Jordan MH, Snider Jr RH, Moore CF, Lewis M, Silva OL, Becker KL 1992 Serum procalcitonin as an index of inhalation injury in burns. Horm Metab Res 24:439-442
102. Müller B, Becker KL, Schächinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R 2000 Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28:977-983
103. Davis TME, Assicot M, Bohuon C, St. John A, Li GQ, Anh TK. 1994 Serum procalcitonin concentrations in acute malaria. Trans R Soc Trop Med Hyg 88:670-671
104. Nylén ES, Alarifi A, Snider RH, Becker KL, Alzeer A 1997 The effect of classical heat stroke on serum procalcitonin. Crit Care Med 25:1362-1365
105. Nylén ES, Snider RH, Thompson KA, Rohatge P, Becker KL 1996 Pneumonitis-associated hyperprocalcitonemia. Am J Med Sci 312:12-18
106. Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W 2000 Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 28: 950-957
107. Rau B, Steinbach G, Gansauge F, Mayer JM, Crunert A, Beger HG 1997 The potential role of procalcitonin and interleukin in the production of prediction of necrosis in acute pancreatitis. Gut 41:832-840
108. Molter GP, Soltesz S, Kottke R, Wilhelm W, Biedler A, Silomon M 2003 Procalcitonin plasma concentrations and systemic inflammatory response following different types of surgery. Anaesthesist 52:210-217
109. Nishikura T 1999 Procalcitonin (PCT) production in a thyroidectomized patient. Intensive Care Med 25:1031
110. Wrenger S, Kahne T, Bohuon C, Weglohner W, Ansorge S, Reinhold D 2000 Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV). FEBS Lett 466:155-159
111. Ittner L, Born W, Rau B, Stembach G, Fischer JA 2002 Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma. Eur J Endocrinol 147:727-731
112. Nylén ES, Müller B, Becker KL, Snider RH 2003 The future diagnostic role of procalcitonin levels: the need for improved sensitivity. Clin Infect Dis 36:823-824
113. Becker KL, Snider RH, Moore CF, Monaghan KG, Silva OL 1979 Calcitonin in extrathyroidal tissues of man. Acta Endocrinol 92:746-751
114. Russwurm S, Stonans L, Stonane E, Wiederhold M, Luber A, Zipfel PF, Deigner H-P, Reinhart K 2001 Procalcitonin and CGRP-1 mRNA expression in various human tissues. Shock 16:109-112
115. Müller B, White JC, Nylén ES, Snider RH, Becker KL, Habener JF 2001 Ubiquitous expression of the calcitonin-1 gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 86:396-404
116. Linscheid P, Seboek D, Nylén ES, Langer I, Schlatter M, Keller U, Becker KL, Müller B 2003 In vitro and in vivo calcitonin-1 gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 144:5578-5584
117. Burgess TL, Kelly RB 1987 Constitutive and regulated secretion of proteins. Annu Rev Cell Biol 3:243-293
118. Bruemmer-Smith S, Stübber F, Schroeder S 2001 Protective functions of intracellular heat-shock protein (HSP) 70-expression in patients with severe sepsis. Intensive Care Med 27:1835-1841
119. Dybdahl B, Wahba A, Lien E, Flo TH, Waage A, Qureshi N, Sellevold OF, Espevik T, Sundan A 2002 Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation 105:685-690
120. Xu Q, Schett G, Perschinka H, Mayr M, Egger G, Oberhollenzer F, Willeit J, Kiechl S, Wick G 2000 Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102:14-20
121. Dana RC, Welch WJ, Deftos LJ 1990 Heat shock proteins bind calcitonin. Endocrinology 126:672-674
122. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM 1982 Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298:240-244
123. Nelkin BD, Rosenfeld KI, de Bustros A, Leong SS, Roos BA, Baylin SB 1984 Structure and expression of a gene encoding human calcitonin and calcitonin gene related peptide. Biochem Biophys Res Commun 123:648-655
124. Wimalawansa SJ 1997 Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol 11:167-239
125. Katafuchi T, Kikumoto K, Hamano K, Kangawa K, Matsuo H, Minamino N 2003 Calcitonin receptor-stimulating peptide, a new member of the calcitonin gene-related peptide family. Its isolation from porcine brain, structure, tissue distribution, and biological activity. J Biol Chem 278:12046-12054
126. Suarez-Domenech VS, Nylén ES, White JC, Snider RH, Becker KL, Landmann R, Müller B 2001 Calcitonin gene-related peptide expression in sepsis: postulation of microbial infection-specific response elements within the calcitonin I gene promoter. J Investig Med 49:514-521
127. Steinwald PM, Whang KT, Becker KL, Snider RH, Nylén ES, White JC 1999 Elevated calcitonin precursor levels are related to mortality in an animal model of sepsis. Crit Care 3:11-16
128. Whang KT, Vath SD, Becker KL, Snider RH, Nylén ES, Müller B, Li Q, Tamarkin L, White JC 2000 Procalcitonin and proinflammatory cytokine interactions in sepsis. Shock 14:73-78
129. Nylén ES, Whang KT, Steinwald PM, Snider RH, White JC, Becker KL 1998 Procalcitonin increases mortality and procalcitonin recognizing antiserum improves mortality in an experimental model of sepsis. Crit Care Med 26: 1001-1006
130. Wagner KE, Vath SD, Snider RH, Nylén ES, Becker KL, Müller B, White JC 2002 Early immunoneutralization of calcitonin in precursors markedly attenuates the adverse physiology response to sepsis in pigs. Crit Care Med 30:2313-2321
131. Martinez JM, Wagner KE, Snider RH, Nylén ES, Müller B, Sarani B, Becker KL, White JC 2001 Late immunoneutralization of procalcitonin arrests in the progression of lethal porcine sepsis. Surg Infect (Larchmt) 2:193-203
132. Becker KL, Bivins LE, Radfar RH, Snider RH, Moore CF, Silva OL 1978 Study of calcitonin heterogeneity using a radioreceptor assay. Horm Metab Res 10:457-458
133. Burns DM, Forstrom JM, Friday KE, Howard GA, Roos BA 1989 Procalcitonin's amino-terminal cleavage peptide is a bone-cell mitogen. Proc Natl Acad Sci USA 86:9519-9523
134. 2-terminal cleavage peptide has no mitogenic effect on normal human osteoblast-like cells. J Bone Miner Res 6:489-493
135. Wright DR, Voelkel EF, Sides KM, Tice JE, Tashjian Jr AH 1977 Heterogeneous forms of human calcitonin: direct assessment of biologic activity. Clin Res 25:404A
136. Horton JE, Oppenheim JJ, Mergenhagen SE, Raisz LG 1974 Macrophage-lymphocyte synergy in thé production of osteoclast activating factor. J Immunol 113:1278-1287
137. Quinn JM, Neale S, Fujikawa Y, McGee JO, Athanasou NA 1998 Human osteoclast formation from monocytes, peritoneal macrophages, and bone marrow cells. Calcif Tissue Int 62:527-531
138. Shui C, Riggs BL, Khosla S 2002 The immunosuppressant rapamycin, alone or with transforming growth factor-β, enhances osteoclast differentiation of RAW 264:7 monocyte/macrophage cells in the presence of RAMP-ligand. Calcif Tissue Int 71:437-446
139. Miyamoto N, Higuchi Y, Mori K, Ito M, Tsurudome M, Nishio M, Yamada H, Sudo A, Kato K, Uchida A, Ito Y 2002 Human osteosarcoma-derived cell lines produce soluble factor(s) that induce differentiation of blood monocytes to osteoclast-like cells. Int Immunopharmacol 2:25-38
140. Horton JE, Raisz LG, Simmons HA, Oppenheim JJ, Mergenhagen SE 1972 Bone resorbing activity in supernatant fluid from cultured peripheral blood leukocytes. Science 177:793-795
141. Dominguez JH, Mundy GR 1980 Monocytes mediate osteoclastic bone resorption by prostaglandin production. Calcif Tissue Int 31:29-34
142. Marx SJ, Aurbach GD, Gavin III JR, Buell DW 1974 Calcitonin receptors on cultured human lymphocytes. J Biol Chem 249:6812-6816
143. Body JJ, Gilbert F, Nejai S, Fernandez G, Van Langendonck A 1990 Calcitonin receptors on circulating normal human lymphocytes. J Clin Endocrinol Metab 71:675-681
144. Perry 3rd HM, Kahn AJ, Chappel JC, Kohler G, Teitelbaum SL, Peck WA 1983 Calcitonin response in circulating human lymphocytes. Endocrinology 113:1568-1573
145. Stock JL, Coderre JA 1982 Calcitonin and parathyroid hormone inhibit accumulation of cyclic AMP in stimulated human mononuclear cells. Biochem Biophys Res Commun 109:935-942
146. Takahashi S, Goldring S, Katz M, Hilsenbeck S, Williams R, Roodman GD 1995 Down-regulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest 167-171
147. MacManus JP, Whitfield JF 1970 Inhibition by thyrocalcitonin of the mitogenic actions of parathyroid hormone and cyclic adenosine-3′,5′- monophosphate on rat thymocytes. Endocrinology 86:934-939
148. 1. J Cell Physiol 80:315-328
149. Sacerdote P, Bianchi M, Panerai AE 1990 Human monocyte chemotactic activity of calcitonin and somatostatin-related peptides: modulation by chronic peptide treatment. J Clin Endocrinol Metab 70:141-148
150. Adami S, Suppi R, Residori M, Braga V, Zamboni M, LoCascio V 1988 Intramuscular administration of salmon calcitonin impairs delayed cutaneous hypersensitivity. Bone Miner 4:91-94
151. 2 microglobulin concentration. Calcif Tissue Int 37:367-371
152. Abdullahi SE, Arrigoni E, Martelli A, Bram E, Franco L, Velo GP 1977 Effects of calcitonin on different inflammatory models. Agents Actions 7:533-538
153. Aida S, Okawa-Takatsuji M, Aotsuka S, Shimoji K, Yokohari R 1994 Calcitonin inhibits production of immunoglobulins, rheumatoid factor and interleukin-1 by mononuclear cells from patients with rheumatoid arthritis. Ann Rheum Dis 53:247-249
154. Wiedermann FJ, Kaneider NC, Egger P, Tiefenthaler W, Wiedermann CJ, Lindner KH, Schobersberger W 2002 Migration of human monocytes in response to procalcitonin. Crit Care Med 30:1112-1117
155. + mononuclear cells to katacaldn. J Bone Miner Res 17:1872-1882
156. Monneret G, Arpin M, Venet F, Maghni K, Debard AL, Pachot A, Lepape A, Bienvenu J 2003 Calcitonin gene related peptide and N-procalcitonin modulate CD11b up-regulation in lipopolysaccharide activated monocytes and neutrophils. Intensive Care Med 29:923-928
157. Müller B, Becker KL, Snider RH, Nylén ES, White JC, Struck J, Procalcitonin induces the synthesis of inflammatory cytokines by human peripheral blood mononuclear cells. Proc Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, CA, 1999
158. Ochoa JB, Udekwu AO, Billiar TR, Curran RO, Cerra FB, Simmons RL, Peitzman AB 1991 Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214:612-626
159. Kilbourne RG, Traber DL, Szabo C 1997 Nitric oxide and shock. Dis Mon 5:277-348
160. Hoffman G, Czechowski M, Schloesser M, Schobersberger W 2002 Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 30:2091-2095
161. Müller B, Becker KL, Kränzlin H, Schächinger PR, Huber PR, Nylén ES, Snider RH, White JC, Schmidt-Gayk H, Zimmerli W, Ritz R 2000 Disordered calcium homeostasis of sepsis: association with calcitonin precursors. Eur J Clin Investig 30:823-831
162. Lind L, Carlstedt F, Rastad J, Stiernström H, Stridsberg M, Ljunggren Ö, Wide L, Larsson A, Hellman P, Ljunghall S 2000 Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med 28:93-99
163. 2+: a critical link in the pathophysiology of sepsis? Proc Natl Acad Sci USA 90:3933-3937
164. Zaloga GP, Washburn D, Ward Black K, Prielipp R 1993 Human sepsis increases lymphocyte intracellular calcium. Crit Care Med 21:196-202
165. Carlon GC, Howland WS, Goldiner PL, Kahn RC, Bertoni G, Turnbull AD 1978 Adverse effects of calcium administration. Arch Surg 113:882-885
166. Carlon GC, Howland WS, Kahn RC, Schweizer O 1980 Calcium chloride administration in normocalcemic critically ill patients. Crit Care Med 8:209-212
167. Zaloga GP, Sayer A, Black KW, Prielipp R 1992 Low dose calcium administration increases mortality during septic peritonitis in rats. Circ Shock 37: 226-229
168. Teti A, Paniccia R, Goldring SR 1995 Calcitonin increases cytosolic free calcium concentration via capacitative calcium influx. J Biol Chem 270:16666-166670
169. Gesek FA, Friedman PA 1993 Calcitonin stimulates calcium transport in distal convoluted tubules. Am J Physiol 244:F744-F751
170. Stroop SD, Moore EE 1995 Intracellular calcium increases mediated by a recombinant human calcitonin receptor. J Bone Miner Res 10:524-532
171. Whang KT, Snider RS, White JC, Becker KL, Steinwald PM, Müller B, Nylén ES 1998 Impact of precalcitonin peptides on calcium in experimental sepsis. Program of the 80th Annual Meeting of The Endocrine Society, New Orleans, LA, 1998, p 241 (Abstract P1-594)
172. Ichinose M, Sawada M 1996 Enhancement of phagocytosis by calcitonin gene-related peptide (CGRP) in cultured mouse peritoneal macrophages. Peptides 17:1405
173. Clementi G, Caruso A, Cutuli VM 1999 Antiinflammatory activity of adrenomedullin in the acetic acid peritonitis in rats. Life Sci 65:PL203
174. Isumi Y, Kubo A, Katafuchi T, Kangawa K, Minamino N 1999 Adrenomedullin suppresses interleukin-1-β-induced tumor necrosis factor-α production in Swiss 3T3 cells. FEBS Lett 463:110-114
175. Stangl K, Laule M, Richter C, Stangl V, Koch J, Göktas Ö, Baumann G, Oschietzig T 2001 Pulmonary adrenomedullin counteracts deterioration of coronary flow and myocardial performance evoked by pulmonary endothelins in experimental acute respiratory distress syndrome. Crit Care Med 29:1027-1032
176. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM 1998 RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-339
177. Christopoulos A, Christopoulos G, Morfis M, Udawela M, Laburthe M, Couvinyau A, Kuwasako K, Tilakorathe N, Sexton PM 2003 Novel receptor partners and function of receptor activity-modifying proteins. J Biol Chem 278:3293-3297
178. Born W, Fischer JA, Muff R 2002 Receptors for calcitonin gene-related peptide, adrenomedullin and amylin: the contributions of novel receptor activity-modifying proteins. Receptors Channels 8:201-209
179. Dandona P, Nix D, Wilson M, Aljada A, Love J, Assicot M, Bohuon C 1994 Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79:1605-1608
180. Preas HL, Nylén ES, Snider RH, Becker KL, White JC, Agosit JM, Suffredini AF 2001 Effects of antiinflammatoiy agents on serum levels of calcitonin precursors during human experimental endotoxemia. J Infect Dis 184:373-376
181. Suffredini AF, Hochstein HD, McMahon FG 1999 Dose-related related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli 0:113 endotoxin. J Infect Dis 179:1278-1282
182. Suffredini AF, O'Grady NP 1999 Pathophysiologic responses to endotoxin in humans. In: Braude H, Opal SM, Vogel SN, Morrison DC, eds. Endotoxin in health and disease. 1st ed. New York: Marcel Dekker; 817-830
183. Nylén ES, Alarifi AA 2001 Humoral markers of severity and prognosis of critical illness. Best Pract Res Clin Endocrinol Metab 15:553-573
184. Alarifi AA, Van Den Berghe GH, Snider RH, Becker KL, Müller B, Nylén ES 2001 Endocrine markers and mediators in critical illness. In: Becker KL, ed. Principles and practice of endocrinology and metabolism. Philadelphia: Lippincott, Williams and Wilkins; 2077-2087
185. Van Amersfoort ES, Van Berkel TJ, Kuiper J 2003 Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 16:379-414
186. Riedemann NC, Guo RF, Ward PA 2003 The enigma of sepsis. J Clin Invest 112:460-467